Does the science of peptides live up to the hype?
Summary
NPR’s Shortwave examines the surge in synthetic peptide use among fitness influencers and the associated safety concerns. Health reporter Sarah Bowden discusses the lack of human clinical data, risks like cancer promotion, and the prevalence of unregulated gray markets. The episode explores potential FDA regulatory changes, weighing harm reduction strategies against strict safety protocols to mitigate public health risks.
Topics discussed
Intro: Sponsor message and show welcome
What are peptides? The rise in popularity and FDA scrutiny
Sponsors: Schwab, NetSuite, and BetterHelp
Scientific evidence: Lack of human trials and cancer risks
The gray market: Buying unregulated research-grade peptides
Harm reduction: Arguments for regulated compounding pharmacies
FDA decision: Conflict of interest and legal perspectives
Future outlook: Prescription access and insurance coverage
Outro: Credits and final sponsor messages
Listen ad-free on Castria